Citation Tools
PDFImmunotherapy biomarkers
Original research
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group